Measurable Residual Disease in Chronic Lymphocytic Leukemia: Current Understanding and Evolving Role in Clinical Practice Fausto Alfredo Rios-OlaisTalal Hilal ReviewPaper 17 May 2023 Pages: 907 - 928
Utility of Measurable Residual Disease (MRD) Assessment in Mantle Cell Lymphoma Simon WuPiers BlomberyConstantine S. Tam ReviewPaper 30 May 2023 Pages: 929 - 947
Treatment of Adult T-Cell Leukemia/Lymphoma: Established Paradigms and Emerging Directions Robert StuverSteven M. HorwitzZachary D. Epstein-Peterson ReviewPaper 10 June 2023 Pages: 948 - 964
New Developments in Treating RAS-Mutated Metastatic Colorectal Cancer Katleen JanssensChinouk LambrechtsMarc Peeters ReviewPaper 22 May 2023 Pages: 965 - 987
Critical Appraisal of Proton Therapy for Patients with Central Nervous System (CNS) Malignancies Jennifer KahanConstanza MartinezChristina Tsien ReviewPaper 22 May 2023 Pages: 988 - 1003
Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed? Julia Dixon-DouglasSherene Loi ReviewPaper Open access 24 May 2023 Pages: 1004 - 1020
Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia Yan XiaoBingbing HuLiuting Yu ReviewPaper Open access 30 May 2023 Pages: 1021 - 1035
Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia Alexandra RezazadehMichael DeiningerEhab Atallah ReviewPaper 10 June 2023 Pages: 1036 - 1051
Cardio-oncology for Pediatric and Adolescent/Young Adult Patients Drishti TolaniJulia WilcoxNeha Bansal ReviewPaper 10 June 2023 Pages: 1052 - 1070
Interventional Cardio-Oncology: Unique Challenges and Considerations in a High-Risk Population Orly LeivaUsman AlamEric H. Yang ReviewPaper Open access 10 June 2023 Pages: 1071 - 1087
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming Lisa Miller-PhillipsEric A. Collisson ReviewPaper 10 June 2023 Pages: 1088 - 1101
